Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1110-06 Phase IIa Trial in Hunner Type Interstitial Cystitis
jRCT2031240558Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) comparing ONO-1110 once daily with Placebo once daily (2 arms). Primary endpoints: Change in weekly mean of average pain score from baseline and Safety assessments. Started Apr 2025; status: completed.
02
Drugs
ONO-1110
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on jRCT2031240558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240558.